Literature DB >> 12897275

Sequelae of severe respiratory syncytial virus infection in infancy and early childhood among Alaska Native children.

Rosalyn J Singleton1, Greg J Redding, Toby C Lewis, Patricia Martinez, Lisa Bulkow, Barbara Morray, Helen Peters, James Gove, Carol Jones, David Stamey, Deborah F Talkington, Jeffrey DeMain, John T Bernert, Jay C Butler.   

Abstract

OBJECTIVE: In 1993-1996, we conducted a nested case-control study to determine risk factors for hospitalization with respiratory syncytial virus (RSV) infection among Alaska Native infants and young children. In the current study, we returned to former RSV case-patients and their control subjects during 1999-2001 to determine whether children who are hospitalized with RSV at <2 years of age are more likely to develop chronic respiratory conditions.
METHODS: For each former RSV case-patient and control subject from remote villages in southwest Alaska, we reviewed medical records, interviewed parents, performed physical examinations and spirometry, collected sera, and analyzed chest radiographs. Case-patients were identified through surveillance for RSV hospitalization, and matched control subjects without lower respiratory infection (LRI)-related hospitalization were identified.
RESULTS: Hospitalization for RSV infection was associated with a significant increase in wheezing, LRIs, and asthma diagnosis during the first 4 years of life. The association decreased with age and was no longer significant by 5 years of age. However, hospitalization for RSV infection was associated with increased respiratory symptoms and increased chronic productive cough at 5 to 8 years of age. Children who were hospitalized with RSV were not more likely at follow-up to have allergies, eczema, or a positive family history of asthma.
CONCLUSIONS: Severe RSV infection in infancy may produce airway injury, which is manifested in chronic productive cough with or without wheezing and recurrent LRIs. Although the association of RSV infection with wheezing seems to be transient, children remain at higher risk for chronic productive cough at 5 to 8 years of age. RSV prevention modalities may prevent sequelae that occur early and later in childhood.

Entities:  

Mesh:

Year:  2003        PMID: 12897275     DOI: 10.1542/peds.112.2.285

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  21 in total

Review 1.  Evidence for a causal relationship between respiratory syncytial virus infection and asthma.

Authors:  Pingsheng Wu; Tina V Hartert
Journal:  Expert Rev Anti Infect Ther       Date:  2011-09       Impact factor: 5.091

2.  The relationship between in-home water service and the risk of respiratory tract, skin, and gastrointestinal tract infections among rural Alaska natives.

Authors:  Thomas W Hennessy; Troy Ritter; Robert C Holman; Dana L Bruden; Krista L Yorita; Lisa Bulkow; James E Cheek; Rosalyn J Singleton; Jeff Smith
Journal:  Am J Public Health       Date:  2008-04-01       Impact factor: 9.308

3.  The real-life effectiveness of palivizumab for reducing hospital admissions for respiratory syncytial virus in infants residing in Nunavut.

Authors:  Anna Banerji; Vladimir Panzov; Michael Young; Bonita E Lee; Muhammad Mamdani; B Louise Giles; Marguerite Dennis; Johanne Morel; Danny Bisson; Bosco A Paes; Charles Hui; Jim Mahony
Journal:  Can Respir J       Date:  2013-12-23       Impact factor: 2.409

Review 4.  Understanding the mechanisms of viral induced asthma: new therapeutic directions.

Authors:  Nicole G Hansbro; Jay C Horvat; Peter A Wark; Philip M Hansbro
Journal:  Pharmacol Ther       Date:  2008-01-29       Impact factor: 12.310

5.  Risk factors for respiratory syncytial virus bronchiolitis hospital admission in New Zealand.

Authors:  K Grimwood; C Cohet; F J Rich; S Cheng; C Wood; N Redshaw; C W Cunningham; N Pearce; J R Kirman
Journal:  Epidemiol Infect       Date:  2008-01-04       Impact factor: 2.451

Review 6.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

Review 7.  An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children.

Authors:  Harish Nair; Vasundhara R Verma; Evropi Theodoratou; Lina Zgaga; Tanvir Huda; Eric A F Simões; Peter F Wright; Igor Rudan; Harry Campbell
Journal:  BMC Public Health       Date:  2011-04-13       Impact factor: 3.295

8.  Determinants in early life for asthma development.

Authors:  Hugo P S Van Bever
Journal:  Allergy Asthma Clin Immunol       Date:  2009-11-09       Impact factor: 3.406

9.  Enteric helminth-induced type I interferon signaling protects against pulmonary virus infection through interaction with the microbiota.

Authors:  Amanda J McFarlane; Henry J McSorley; Donald J Davidson; Paul M Fitch; Claire Errington; Karen J Mackenzie; Eva S Gollwitzer; Chris J C Johnston; Andrew S MacDonald; Michael R Edwards; Nicola L Harris; Benjamin J Marsland; Rick M Maizels; Jürgen Schwarze
Journal:  J Allergy Clin Immunol       Date:  2017-02-11       Impact factor: 10.793

10.  Severe lower respiratory tract infection in early infancy and pneumonia hospitalizations among children, Kenya.

Authors:  Patrick Kiio Munywoki; Eric O Ohuma; Mwanajuma Ngama; Evasius Bauni; J Anthony G Scott; D James Nokes
Journal:  Emerg Infect Dis       Date:  2013-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.